touchPODCAST

touchMDT for touchRESPIRATORY

Listen to a multidisciplinary team of experts as they explore the symptoms of EoE and their impact on patients in a case-based discussion of an adult newly presenting with food impaction.

The multidisciplinary team 

• Gastroenterologist: Prof. Arjan Bredenoord, The Netherlands

This touchPODCAST is for HCPs only.

This activity is funded by an independent medical educational grant from Regeneron Pharmaceuticals, Inc. and Sanofi. This activity is jointly provided by USF Health and touchIME. 

For further information visit our website: https://touchrespiratoryime.org/mdt-improving-outcomes-in-eoe/

touchMDT for touchRESPIRATORY

Listen to leading experts discuss the environmental, genetic and immunological factors that contribute to the development of eosinophilic oesophagitis. 

The multidisciplinary team

• Allergist/immunologist: Prof. Jonathan Spergel, USA

This touchPODCAST is for HCPs only.

This activity is funded by an independent medical educational grant from Regeneron Pharmaceuticals, Inc. and Sanofi. This medical education is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchrespiratoryime.org/mdt-improving-outcomes-in-eoe/

touchPANEL DISCUSSION for touchINFECTIOUS DISEASES

Listen to three leading experts discuss current and future best practice for the management of non-cystic fibrosis bronchiectasis, including risk factors for acute exacerbations, the management of chronic infection and available and emerging pharmacotherapeutic strategies.

The experts

• Dr Charles Daley – National Jewish Health and University of Colorado, Denver, CO, USA; Icahn School of Medicine at Mount Sinai, New York, NY, USA

This touchPODCAST is for HCPs only.

This activity is funded by an independent medical education grant from Insmed. This activity is jointly provided by USF Health and touchIME. 

For further information visit our website: https://touchinfectiousdiseasesime.org/best-practice-for-management-of-non-cystic fibrosis-bronchiectasis/

touchPANEL DISCUSSION for touchRESPIRATORY

Listen to three leading experts discuss current and future best practice for the management of non-cystic fibrosis bronchiectasis, including risk factors for acute exacerbations, the management of chronic infection and available and emerging pharmacotherapeutic strategies.

The experts

• Dr Charles Daley – National Jewish Health and University of Colorado, Denver, CO, USA; Icahn School of Medicine at Mount Sinai, New York, NY, USA

This touchPODCAST is for HCPs only.

This activity is funded by an independent medical education grant from Insmed. This activity is jointly provided by USF Health and touchIME. 

For further information visit our website: https://touchrespiratoryime.org/best-practice-for-management-of-non-cystic fibrosis-bronchiectasis/

touchMDT for touchONCOLOGY

Listen to key experts from a multidisciplinary team, plus a patient advocate, consider real-life perspectives from patients with chronic myeloid leukaemia, and what HCPs can learn from them to improve outcomes

The multidisciplinary team 

• Haematologist: Prof. Dr med. Andreas Hochhaus, Germany

This touchPODCAST is for HCPs only.

This activity is funded by an independent medical education grant from Novartis. This medical education is provided by touchIME.

For further information visit our website: https://touchoncology.com/education/mdt-management-cml-later-line-setting-holistic-approach/

touchMDT for touchONCOLOGY

Listen to key experts from a multidisciplinary team discuss strategies to maximize the quality of life of patients with chronic myeloid leukaemia in the later-line setting

The multidisciplinary team 

• Pharmacist: Dr Bee Kim Tan, Malaysia

This touchPODCAST is for HCPs only.

This activity is funded by an independent medical education grant from Novartis. This medical education is provided by touchIME.

For further information visit our website: https://touchoncology.com/education/mdt-management-cml-later-line-setting-holistic-approach/

touchMDT for touchONCOLOGY

Listen to key experts from a multidisciplinary team explore how to minimize toxicities while maximizing treatment benefit for patients with chronic myeloid leukaemia

The multidisciplinary team 

• Nurse specialist: Johan De Munter, Belgium

This touchPODCAST is for HCPs only.

This activity is funded by an independent medical education grant from Novartis. This medical education is provided by touchIME.

For further information visit our website: https://touchoncology.com/education/mdt-management-cml-later-line-setting-holistic-approach/

touchMDT for touchONCOLOGY

Listen to key experts from a multidisciplinary team discuss the later-line treatment options for chronic myeloid leukaemia, including T315I mutation-positive disease

The multidisciplinary team

• Haematologist: Prof. Dr med. Andreas Hochhaus, Germany

This touchPODCAST is for HCPs only.

This activity is funded by an independent medical education grant from Novartis. This medical education is provided by touchIME.

For further information visit our website: https://touchoncology.com/education/mdt-management-cml-later-line-setting-holistic-approach/

touchMDT for touchONCOLOGY

Listen to a medical oncologist, a urologist and an oncology pharmacist discuss extending the benefit of PARP inhibitors through combinations for the treatment of advanced prostate cancer. 

The multidisciplinary team 

• Medical Oncologist: Dr Wassim Abida, USA

This touchPODCAST is for HCPs only.

This activity is funded by an independent medical education grant from Pfizer. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchoncologyime.org/mdt-parp-inhibitor-combinations-in-advanced-prostate-cancer/

touchMDT for touchONCOLOGY

Listen to a urologist and a medical oncologist discuss key clinical trials investigating PARP inhibitor combinations for the treatment of advanced prostate cancer.

The multidisciplinary team 

• Urologist: Professor Axel Merseburger, Germany

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent medical education grant from Pfizer. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchoncologyime.org/mdt-parp-inhibitor-combinations-in-advanced-prostate-cancer/